Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

BrightSpring Health Services (BTSG) Shares Repurchased (2023 - 2026)

BrightSpring Health Services filings provide 3 years of Shares Repurchased readings, the most recent being $60.0 million for Q1 2026.

On a quarterly basis, Shares Repurchased changed N/A to $60.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $60.3 million, a N/A change, with the full-year FY2025 number at $43.2 million, up 6542.0% from a year prior.
Shares Repurchased hit $60.0 million in Q1 2026 for BrightSpring Health Services, up from $325000.0 in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $60.0 million in Q1 2026 to a low of $325000.0 in Q4 2023.
Median Shares Repurchased over the past 3 years was $325000.0 (2023), compared with a mean of $15.2 million.